← FDA Drug Approvals (Drugs@FDA)
OXCARBAZEPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TWI PHARMS INC · Approved 2018-11-29
Drug application
- FDA Application #
ANDA206576- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXCARBAZEPINE
- Generic name
- Oxcarbazepine
- Active ingredients
- OXCARBAZEPINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- TWI PHARMS INC
- First approval
- 2018-11-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown